Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Tidepool and Abbott’s new data integration partnership will simplify data sharing by automating data upload to Tidepool for patients wearing FreeStyle Libre sensors, and create more efficient ...

Tidepool collaborates with Abbott for seamless data integration ... to initiate the connection with their patients using FreeStyle Libre 2 and 3 systems in clinic or remotely.

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio ... Clinics and health systems using Tidepool+ will be able to initiate the connection with their ...

We are excited to work with Abbott to empower healthcare providers ... initiate the connection with their patients using FreeStyle Libre 2 and 3 systems in clinic or remotely.

FreeStyle Libre 2 sensors will be phased out in the UK by the end of August 2025, meaning that people living with diabetes who use the sensors will need to transition to using FreeStyle Libre 2 Plus ...